Russia starts testing coronavirus vaccine prototypes on animals

Published 03/20/2020, 03:15 AM
Updated 03/20/2020, 03:20 AM

MOSCOW (Reuters) - Russian scientists have begun testing prototypes of potential vaccines against the new coronavirus on animals in a laboratory in Siberia, Russia's consumer health regulator said on Friday.

Russia has reported 199 coronavirus cases so far, less than in many other European countries, but the figure has risen sharply in recent days. One person diagnosed with the virus has died.

Scientists in the Vektor State Virology and Biotechnology Centre in the city of Novosibirsk have developed vaccine prototypes based on six different technological platforms and began tests on Monday to try to work out how effective they are and in what doses they could be administered, the regulator said.

Scientists around the world have warned that the development of a vaccine is a lengthy and complex process that might only yield something for broader use in the next 12-18 months.

"Most often, laboratory mice and rats are used for such studies, ferrets, lower primates and other special lines of laboratory animals are also used," the Russian regulator, Rospotrebnadzor, said in a statement.

© Reuters. Specialists put on protective gear inside a hospital for patients infected with coronavirus disease in Moscow

Scientists expect it will be possible to start rolling out a vaccine in the last three months of 2020, it added.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.